New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 30, 2014
07:47 EDTESRXExpress Scripts valuation already reflects Q1 miss, says Jefferies
Jefferies believes the valuation of Express Scripts shares "more than adequately" reflects the company's miss in Q1. The firm finds the stock attractive and maintains a Buy rating on the name with an $86 price target.
News For ESRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 5, 2016
10:08 EDTESRXExpress Scripts calls active
Subscribe for More Information
January 29, 2016
10:13 EDTESRXExpress Scripts to exclude Valeant's Glumetza from formulary
Subscribe for More Information
January 28, 2016
06:24 EDTESRXAnthem added to Focus List at Citi
Citi analyst Ralph Giacobbe added Anthem (ANTM) to his firm's Focus List. As Anthem and Express Scripts (ESRX) continue to negotiate their pharmacy benefits manager contract, the analyst sees UnitedHealth (UNH) as a potential alternative for Anthem. Regardless of the outcome, Anthem is in the "driver's seat for significant savings/upside," which is not reflected in the stock. Giacobbe tells investors in a research note. He keeps a Buy rating on the name with a $172 price target.
January 25, 2016
15:24 EDTESRXExpress Scripts off highs after Clinton tweets critical NPR report
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use